Phytobezoar Associated with Levodopa-carbidopa Intestinal Gel Infusion in Patients with Parkinson's Disease: A Case Report and Literature Review

被引:2
|
作者
Ueno, Tatsuya [1 ]
Hanabata, Norihiro [2 ]
Katagai, Atsuko [1 ]
Okudera, Rena [1 ,3 ]
Arai, Akira [1 ]
Tomiyama, Masahiko [4 ]
机构
[1] Aomori Prefectural Cent Hosp, Dept Neurol, Aomori, Japan
[2] Aomori Prefectural Cent Hosp, Dept Gastroenterol, Aomori, Japan
[3] Natl Def Med Coll, Dept Internal Med, Div Neurol, Tokorozawa, Saitama, Japan
[4] Hirosaki Univ, Dept Neurol, Grad Sch Med, Hirosaki, Aomori, Japan
关键词
levodopa-carbidopa intestinal gel; parkinson's disease; phytobezoar; device-aided therapy; J-tube; gastrointestinal symptom; COMPLICATION;
D O I
10.2169/internalmedicine.7210-21
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel (LCIG) is an established device-aided therapy for advanced Parkinson's disease (PD). Phytobezoar associated with LCIG is a rare device-related complication and presents with exacerbations of gastrointestinal and PD symptoms. We herein report the case of a phytobezoar that was formed at a knot on the pigtail-shaped J-tube and developed only in association with postprandial abdominal pain, similar to a feeling of a tube being pulled in without an exacerbation of PD symptoms. Such abdominal pain may be a warning sign of phytobezoar in LCIG-treated patients. Despite device-related complications, high-pressure alarms are not always present, and PD symptoms are not always exacerbated.
引用
收藏
页码:3317 / 3320
页数:4
相关论文
共 50 条
  • [31] Effects of rehabilitation on reducing dyskinesias in a Parkinson's disease patient abusing therapy with levodopa-carbidopa intestinal gel: a paradigmatic case report and literature review
    Petraroli, A.
    de Sire, A.
    Pino, I
    Moggio, L.
    Marinaro, C.
    Demeco, A.
    Ammendolia, A.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2021, 35 (04): : 1323 - 1329
  • [32] Levodopa-Carbidopa Intestinal Gel in Parkinson's Disease: A Systematic Review and Meta-Analysis
    Wang, Libo
    Li, Jia
    Chen, Jiajun
    FRONTIERS IN NEUROLOGY, 2018, 9
  • [33] Comprehensive assessment of levodopa-carbidopa intestinal gel for Turkish advanced Parkinson's disease patients
    Karadag, Yesim Sucullu
    Saltoglu, Tugce
    Kucukdagli, Fadime Erdogan
    Ozturk, Omer
    Koseoglu, Tankut
    Altiparmak, Emin
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2021, 51 (01) : 84 - 89
  • [34] Does levodopa-carbidopa intestinal gel in Parkinson's disease patients increase the risk on polyneuropathy?
    Moes, H.
    Drent, M.
    Laar, T.
    MOVEMENT DISORDERS, 2017, 32
  • [35] Reply to Letter: Suicide in Parkinson's Disease Patients Treated With Levodopa-Carbidopa Intestinal Gel
    Fernandez, Hubert H.
    Standaert, David G.
    Chatamra, Krai
    Benesh, Janet A.
    MOVEMENT DISORDERS, 2015, 30 (10) : 1435 - 1436
  • [36] Effect of levodopa-carbidopa intestinal gel on resting tremor in patients with advanced Parkinson's disease
    Fernandez, H. H.
    Dubow, J.
    Robieson, W. Z.
    Chatamra, K.
    Eaton, S.
    Benesh, J. A.
    Odin, P.
    MOVEMENT DISORDERS, 2015, 30 : S84 - S85
  • [37] Efficacy of levodopa-carbidopa intestinal gel compared to oral levodopa-carbidopa in advanced Parkinson's disease: Sensitivity and responder analyses
    Boyd, J. T.
    Fernandez, H. H.
    Slevin, J. T.
    Espay, A. J.
    Standaert, D. G.
    Pritchett, Y.
    Zhang, W.
    Chatamra, K.
    Widnell, K. L.
    Benesh, J.
    MOVEMENT DISORDERS, 2013, 28 : S143 - S143
  • [38] Effect of Levodopa-Carbidopa Intestinal Gel on Resting Tremor in Patients with Advanced Parkinson's Disease
    Fernandez, Hubert
    Dubow, Jordan
    Robieson, Weining
    Chatamra, Krai
    Eaton, Susan
    Benesh, Janet
    Odin, Per
    NEUROLOGY, 2016, 86
  • [39] Acalculous cholecystitis associated with levodopa-carbidopa intestinal infusion therapy: A case report
    Torres, Viviana
    Gonzalez-Ortega, Guillermo
    Suarez, Antoni
    Garrido, Alicia
    Camara, Ana
    Compta, Yaroslau
    Valldeoriola, Francesc
    CLINICAL PARKINSONISM & RELATED DISORDERS, 2022, 7
  • [40] Efficacy of levodopa-carbidopa intestinal gel in patients with advanced Parkinson's disease: Subgroup analyses
    Standaert, D. G.
    Slevin, J. T.
    Espay, A. J.
    Boyd, J. T.
    Fernandez, H. H.
    Pritchett, Y.
    Zhang, W.
    Chatamra, K.
    Widnell, K. L.
    Benesh, J.
    MOVEMENT DISORDERS, 2013, 28 : S143 - S144